Dawn F. Ionescu

4.9k total citations
54 papers, 3.3k citations indexed

About

Dawn F. Ionescu is a scholar working on Pharmacology, Biological Psychiatry and Experimental and Cognitive Psychology. According to data from OpenAlex, Dawn F. Ionescu has authored 54 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Pharmacology, 28 papers in Biological Psychiatry and 24 papers in Experimental and Cognitive Psychology. Recurrent topics in Dawn F. Ionescu's work include Treatment of Major Depression (41 papers), Tryptophan and brain disorders (28 papers) and Mental Health Research Topics (15 papers). Dawn F. Ionescu is often cited by papers focused on Treatment of Major Depression (41 papers), Tryptophan and brain disorders (28 papers) and Mental Health Research Topics (15 papers). Dawn F. Ionescu collaborates with scholars based in United States, Puerto Rico and Belgium. Dawn F. Ionescu's co-authors include Carlos A. Zarate, Mark J. Niciu, Erica M. Richards, David A. Luckenbaugh, Nancy E. Brutsché, Jonathan E. Alpert, Cristina Cusin, Maurizio Fava, Jerrold F. Rosenbaum and Daniel C. Mathews and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Molecular Psychiatry.

In The Last Decade

Dawn F. Ionescu

54 papers receiving 3.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dawn F. Ionescu United States	32	2.1k	1.6k	821	658	646	54	3.3k
Ella Daly United States	21	2.4k 1.2×	1.6k 1.0×	758 0.9×	723 1.1×	702 1.1×	64	3.3k
Samuel T. Wilkinson United States	29	2.3k 1.1×	1.2k 0.7×	500 0.6×	584 0.9×	950 1.5×	89	3.3k
Mark J. Niciu United States	38	2.2k 1.0×	1.9k 1.2×	736 0.9×	1.1k 1.7×	702 1.1×	66	4.3k
Andrew M. Perez United States	10	2.8k 1.3×	2.2k 1.4×	579 0.7×	861 1.3×	615 1.0×	15	3.4k
Nancy Diazgranados United States	25	2.6k 1.3×	2.2k 1.4×	574 0.7×	1.3k 2.0×	1.2k 1.8×	79	4.5k
Cristina Cusin United States	35	1.5k 0.7×	1.1k 0.7×	597 0.7×	1.0k 1.6×	1.4k 2.1×	102	3.8k
Richard C. Shelton United States	31	1.5k 0.7×	1.1k 0.7×	561 0.7×	818 1.2×	905 1.4×	65	3.9k
Giacomo Salvadore United States	25	1.7k 0.8×	1.6k 1.0×	408 0.5×	906 1.4×	854 1.3×	51	3.4k
Paul J. Carlson United States	17	2.2k 1.1×	1.9k 1.2×	375 0.5×	1.4k 2.1×	699 1.1×	24	3.7k
Rosanne Lane United States	23	1.8k 0.9×	1.2k 0.8×	508 0.6×	546 0.8×	1.2k 1.9×	41	3.2k

Countries citing papers authored by Dawn F. Ionescu

Since Specialization

Citations

This map shows the geographic impact of Dawn F. Ionescu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dawn F. Ionescu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dawn F. Ionescu more than expected).

Fields of papers citing papers by Dawn F. Ionescu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dawn F. Ionescu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dawn F. Ionescu. The network helps show where Dawn F. Ionescu may publish in the future.

Co-authorship network of co-authors of Dawn F. Ionescu

This figure shows the co-authorship network connecting the top 25 collaborators of Dawn F. Ionescu. A scholar is included among the top collaborators of Dawn F. Ionescu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dawn F. Ionescu. Dawn F. Ionescu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jamieson, Carol, Carla M. Canuso, Dawn F. Ionescu, et al.. (2023). Effects of esketamine on patient-reported outcomes in major depressive disorder with active suicidal ideation and intent: a pooled analysis of two randomized phase 3 trials (ASPIRE I and ASPIRE II). Quality of Life Research. 32(11). 3053–3061. 5 indexed citations

Hoeppner, Bettina B., Marlene P. Freeman, Martina Flynn, et al.. (2022). Effect of Concomitant Benzodiazepines on the Antidepressant Effects of Ketamine. The Journal of Clinical Psychiatry. 84(1). 4 indexed citations

Canuso, Carla M., Dawn F. Ionescu, Xiang Li, et al.. (2021). Esketamine Nasal Spray for the Rapid Reduction of Depressive Symptoms in Major Depressive Disorder With Acute Suicidal Ideation or Behavior. Journal of Clinical Psychopharmacology. 41(5). 516–524. 51 indexed citations

Fu, Dong‐Jing, Dawn F. Ionescu, Xiang Li, et al.. (2020). Esketamine Nasal Spray for Rapid Reduction of Major Depressive Disorder Symptoms in Patients Who Have Active Suicidal Ideation With Intent. The Journal of Clinical Psychiatry. 81(3). 148 indexed citations

Sydnor, Valerie J., Amanda E. Lyall, Suheyla Cetin‐Karayumak, et al.. (2020). Studying pre-treatment and ketamine-induced changes in white matter microstructure in the context of ketamine’s antidepressant effects. Translational Psychiatry. 10(1). 432–432. 25 indexed citations

Ionescu, Dawn F., Dong‐Jing Fu, Xin Qiu, et al.. (2020). Esketamine Nasal Spray for Rapid Reduction of Depressive Symptoms in Patients With Major Depressive Disorder Who Have Active Suicide Ideation With Intent: Results of a Phase 3, Double-Blind, Randomized Study (ASPIRE II). The International Journal of Neuropsychopharmacology. 24(1). 22–31. 165 indexed citations

Salloum, Naji C., Maurizio Fava, Rebecca S. Hock, et al.. (2019). Time to relapse after a single administration of intravenous ketamine augmentation in unipolar treatment-resistant depression. Journal of Affective Disorders. 260. 131–139. 22 indexed citations

Salloum, Naji C., Maurizio Fava, Marlene P. Freeman, et al.. (2018). Efficacy of intravenous ketamine treatment in anxious versus nonanxious unipolar treatment-resistant depression. Depression and Anxiety. 36(3). 235–243. 36 indexed citations

Ionescu, Dawn F., Kate H. Bentley, Matthias Eikermann, et al.. (2018). Repeat-dose ketamine augmentation for treatment-resistant depression with chronic suicidal ideation: A randomized, double blind, placebo controlled trial. Journal of Affective Disorders. 243. 516–524. 126 indexed citations

10.

Niciu, Mark J., Dipavo Banerjee, David A. Luckenbaugh, et al.. (2017). The antidepressant efficacy of subanesthetic-dose ketamine does not correlate with baseline subcortical volumes in a replication sample with major depressive disorder. Journal of Psychopharmacology. 31(12). 1570–1577. 18 indexed citations

11.

Tyler, Marshall, et al.. (2017). Classics in Chemical Neuroscience: Ketamine. ACS Chemical Neuroscience. 8(6). 1122–1134. 82 indexed citations

12.

Ionescu, Dawn F., Michaela B. Swee, Kara J. Pavone, et al.. (2016). Rapid and Sustained Reductions in Current Suicidal Ideation Following Repeated Doses of Intravenous Ketamine. The Journal of Clinical Psychiatry. 77(6). e719–e725. 82 indexed citations

13.

Berg, Hannah, Elizabeth D. Ballard, David A. Luckenbaugh, et al.. (2016). Recognition of emotional facial expressions in anxious and nonanxious depression. Comprehensive Psychiatry. 70. 1–8. 18 indexed citations

14.

Richards, Erica M., Daniel C. Mathews, David A. Luckenbaugh, et al.. (2016). A randomized, placebo-controlled pilot trial of the delta opioid receptor agonist AZD2327 in anxious depression. Psychopharmacology. 233(6). 1119–1130. 59 indexed citations

15.

Ionescu, Dawn F., Richard C. Shelton, Lee Baer, et al.. (2016). Ziprasidone augmentation for anxious depression. International Clinical Psychopharmacology. 31(6). 341–346. 8 indexed citations

16.

Ballard, Elizabeth D., Dawn F. Ionescu, Jennifer L. Vande Voort, et al.. (2014). Increased fear-potentiated startle in major depressive disorder patients with lifetime history of suicide attempt. Journal of Affective Disorders. 162. 34–38. 29 indexed citations

17.

Niciu, Mark J., David A. Luckenbaugh, Dawn F. Ionescu, et al.. (2014). Clinical Predictors of Ketamine Response in Treatment-Resistant Major Depression. The Journal of Clinical Psychiatry. 75(5). e417–e423. 118 indexed citations

18.

Ionescu, Dawn F., David A. Luckenbaugh, Mark J. Niciu, et al.. (2014). Effect of Baseline Anxious Depression on Initial and Sustained Antidepressant Response to Ketamine. The Journal of Clinical Psychiatry. 75(9). e932–e938. 90 indexed citations

19.

Niciu, Mark J., David A. Luckenbaugh, Dawn F. Ionescu, et al.. (2014). Ketamine’s Antidepressant Efficacy is Extended for at Least Four Weeks in Subjects with a Family History of an Alcohol Use Disorder. The International Journal of Neuropsychopharmacology. 18(1). 45 indexed citations

20.

Niciu, Mark J., Dawn F. Ionescu, Daniel C. Mathews, Erica M. Richards, & Carlos A. Zarate. (2013). Second messenger/signal transduction pathways in major mood disorders: moving from membrane to mechanism of action, part I: major depressive disorder. CNS Spectrums. 18(5). 231–241. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact